Ir.geron.com

Geron Corporation

WEBInnovation Passport Designation Awarded to Imetelstat for the Treatment of Lower Risk Myelodysplastic Syndromes Pathway Intended to Expedite Regulatory …

Actived: 9 days ago

URL: https://ir.geron.com/investors/press-releases/press-release-details/2021/Geron-Enters-New-Innovative-Licensing-and-Access-Pathway-in-the-United-Kingdom-for-Imetelstat/default.aspx

Geron Corporation Announces Appointment of Gaurav Aggarwal, …

WEBGeron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Gaurav Aggarwal, M.D., to the …

Category:  Health Go Health

Geron Corporation

WEBImetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS …

Category:  Health Go Health

Geron Announces U.S. Expanded Access Protocol for Imetelstat in …

WEBGeron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that an Expanded Access Protocol (EAP) is available for …

Category:  Health Go Health

Geron Announces Completion of Second Internal Data Reviews for

WEBGeron Corporation (Nasdaq:GERN) today announced that Janssen Research & Development, LLC has completed the second internal data reviews of …

Category:  Health Go Health

Geron Corporation

WEBDesignation would provide 10-year period of marketing exclusivity in the European Union after product approval Patients are currently enrolling in a Geron …

Category:  Health Go Health

Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in

WEBGeron plans to move forward with a Phase 3 clinical trial in refractory myelofibrosis (MF) with overall survival (OS) as a primary endpoint, which is expected to …

Category:  Health Go Health

Geron Corporation

WEBImetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS Geron …

Category:  Health Go Health

Geron Corporation

WEBFOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that five …

Category:  Health Go Health

Geron Corporation

WEBExpanded Part 1 of IMerge is Open for Patient Enrollment Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration …

Category:  Food Go Health

Geron Corporation

WEBStockholders wishing to contact Geron’s Board of Directors, may do so by writing c/o Secretary, Geron Corporation, 919 E. Hillsdale, Suite 250, Foster City, CA 94404, or via …

Category:  Health Go Health

Geron Corporation

WEBFOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the …

Category:  Health Go Health

Geron Enhances Oncology Expertise to Advance Corporate …

WEBGeron Corporation (Nasdaq: GERN) today announced the appointments of Sharon McBain as Vice President, Global Regulatory Affairs and Lynn Bodarky as Vice President, …

Category:  Health Go Health

Geron Corporation

WEBMENLO PARK, Calif., May 22, 2020 (GLOBE NEWSWIRE) - Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing …

Category:  Health Go Health

Geron Announces Positive Data on its Small Molecule Telomerase

WEBFirst In Vivo Proof-of-Concept Showing Impact of a Telomerase Activator in a Model of Human Disease MENLO PARK, Calif., May 19, 2010 - Geron Corporation (Nasdaq: …

Category:  Health Go Health

Geron Announces Experienced Commercial Leadership Hired

WEBLeadership in place for core commercial functions, including in Market Access, Trade Channel Relations, Commercial Operations, Analytics, Marketing, Sales …

Category:  Health Go Health

Geron Corporation

WEBMENLO PARK, Calif., May 27, 2020 (GLOBE NEWSWIRE) - Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the closing …

Category:  Health Go Health

Geron Appoints Susan Molineaux and Daniel Bradbury to

WEBMENLO PARK, Calif., September 28, 2012 - Geron Corporation (Nasdaq: GERN) today announced the appointment of Susan M. Molineaux, Ph.D., and Daniel M. …

Category:  Health Go Health